These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
320 related articles for article (PubMed ID: 26422582)
1. Intracellular delivery of 10-hydroxycamptothecin with targeted nanostructured lipid carriers against multidrug resistance. Liu M; Chen D; Mukerabigwi JF; Chen S; Zhang Y; Lei S; Luo S; Wen Z; Cao Y; Huang X; He H J Drug Target; 2016; 24(5):433-40. PubMed ID: 26422582 [TBL] [Abstract][Full Text] [Related]
2. Intracellular target delivery of 10-hydroxycamptothecin with solid lipid nanoparticles against multidrug resistance. Liu M; Chen D; Wang C; Chen X; Wen Z; Cao Y; He H J Drug Target; 2015; 23(9):800-5. PubMed ID: 25766079 [TBL] [Abstract][Full Text] [Related]
3. Lipid nanoparticles loaded with 10-hydroxycamptothecin-phospholipid complex developed for the treatment of hepatoma in clinical application. Wei W; Shi SJ; Liu J; Sun X; Ren K; Zhao D; Zhang XN; Zhang ZR; Gong T J Drug Target; 2010 Aug; 18(7):557-66. PubMed ID: 20131981 [TBL] [Abstract][Full Text] [Related]
4. [Preparation of PEG-modified nanostructured lipid carriers loaded with hydroxycamptothecin and tissue distribution in mice]. Zhang XX; Gan Y; Yang XG; Zhu CL; Gan L; Nie SF; Pan WS Yao Xue Xue Bao; 2008 Jan; 43(1):91-6. PubMed ID: 18357740 [TBL] [Abstract][Full Text] [Related]
5. Precise Ratiometric Control of Dual Drugs through a Single Macromolecule for Combination Therapy. Luo S; Gu Y; Zhang Y; Guo P; Mukerabigwi JF; Liu M; Lei S; Cao Y; He H; Huang X Mol Pharm; 2015 Jul; 12(7):2318-27. PubMed ID: 26035636 [TBL] [Abstract][Full Text] [Related]
6. PEGylated nanostructured lipid carriers loaded with 10-hydroxycamptothecin: an efficient carrier with enhanced anti-tumour effects against lung cancer. Zhang X; Gan Y; Gan L; Nie S; Pan W J Pharm Pharmacol; 2008 Aug; 60(8):1077-87. PubMed ID: 18644200 [TBL] [Abstract][Full Text] [Related]
7. Intracellular delivery of mitomycin C with targeted polysaccharide conjugates against multidrug resistance. Cao Y; Chen D; Zhao P; Liu L; Huang X; Qi C; Liu Y; He H; Wang Q; Liu Y; Chen S Ann Biomed Eng; 2011 Sep; 39(9):2456-65. PubMed ID: 21701935 [TBL] [Abstract][Full Text] [Related]
8. A pH-responsive prodrug delivery system of 10-HCPT for controlled release and tumor targeting. Liu Y; Li D; Guo X; Xu H; Li Z; Zhang Y; Song C; Fan R; Tang X; Zhang Z Int J Nanomedicine; 2017; 12():2227-2242. PubMed ID: 28356739 [TBL] [Abstract][Full Text] [Related]
9. Arginine-Modified Nanostructured Lipid Carriers with Charge-Reversal and pH-Sensitive Membranolytic Properties for Anticancer Drug Delivery. Sun M; Li J; Zhang C; Xie Y; Qiao H; Su Z; Oupický D; Ping Q Adv Healthc Mater; 2017 Apr; 6(8):. PubMed ID: 28187243 [TBL] [Abstract][Full Text] [Related]
10. Preparation of a dispersible PEGylate nanostructured lipid carriers (NLC) loaded with 10-hydroxycamptothecin by spray-drying. Zhang X; Pan W; Gan L; Zhu C; Gan Y; Nie S Chem Pharm Bull (Tokyo); 2008 Dec; 56(12):1645-50. PubMed ID: 19043233 [TBL] [Abstract][Full Text] [Related]
11. Glycyrrhetinic Acid and TAT Peptide Modified Dual-functional Liposomes for Treatment of Hepatocellular Cancer. Huang S; Ren D; Wu X; Li M; Yu X; Nie X; Wang Y; Wang Y Curr Top Med Chem; 2020; 20(27):2493-2505. PubMed ID: 32703132 [TBL] [Abstract][Full Text] [Related]
12. Preparation and characterization of 10-hydroxycamptothecin loaded nanostructured lipid carriers. Liu K; Sun J; Wang Y; He Y; Gao K; He Z Drug Dev Ind Pharm; 2008 May; 34(5):465-71. PubMed ID: 18473227 [TBL] [Abstract][Full Text] [Related]
13. Formulation of injectable glycyrrhizic acid-hydroxycamptothecin micelles as new generation of DNA topoisomerase I inhibitor for enhanced antitumor activity. Cai J; Luo S; Lv X; Deng Y; Huang H; Zhao B; Zhang Q; Li G Int J Pharm; 2019 Nov; 571():118693. PubMed ID: 31525442 [TBL] [Abstract][Full Text] [Related]
14. Preparation of 10-hydroxycamptothecin-loaded glycyrrhizic acid-conjugated bovine serum albumin nanoparticles for hepatocellular carcinoma-targeted drug delivery. Zu Y; Meng L; Zhao X; Ge Y; Yu X; Zhang Y; Deng Y Int J Nanomedicine; 2013; 8():1207-22. PubMed ID: 23569373 [TBL] [Abstract][Full Text] [Related]
15. Effect of octreotide-polyethylene glycol(100) monostearate modification on the pharmacokinetics and cellular uptake of nanostructured lipid carrier loaded with hydroxycamptothecine. Su Z; Niu J; Xiao Y; Ping Q; Sun M; Huang A; You W; Sang X; Yuan D Mol Pharm; 2011 Oct; 8(5):1641-51. PubMed ID: 21770405 [TBL] [Abstract][Full Text] [Related]
16. Positively charged polypeptide nanogel enhances mucoadhesion and penetrability of 10-hydroxycamptothecin in orthotopic bladder carcinoma. Guo H; Xu W; Chen J; Yan L; Ding J; Hou Y; Chen X J Control Release; 2017 Aug; 259():136-148. PubMed ID: 28062300 [TBL] [Abstract][Full Text] [Related]
17. 10-Hydroxycamptothecin (HCPT) nanosuspensions stabilized by mPEG Yang L; Hong J; Di J; Guo Y; Han M; Liu M; Wang X Int J Nanomedicine; 2017; 12():3681-3695. PubMed ID: 28553107 [TBL] [Abstract][Full Text] [Related]
18. Nanostructured lipid carriers as novel carrier for parenteral delivery of docetaxel. Liu D; Liu Z; Wang L; Zhang C; Zhang N Colloids Surf B Biointerfaces; 2011 Jul; 85(2):262-9. PubMed ID: 21435845 [TBL] [Abstract][Full Text] [Related]
19. Integration of phospholipid-hyaluronic acid-methotrexate nanocarrier assembly and amphiphilic drug-drug conjugate for synergistic targeted delivery and combinational tumor therapy. Li Y; Zhang H; Chen Y; Ma J; Lin J; Zhang Y; Fan Z; Su G; Xie L; Zhu X; Hou Z Biomater Sci; 2018 Jun; 6(7):1818-1833. PubMed ID: 29785434 [TBL] [Abstract][Full Text] [Related]
20. Hyaluronic acid-coated nanostructured lipid carriers for targeting paclitaxel to cancer. Yang XY; Li YX; Li M; Zhang L; Feng LX; Zhang N Cancer Lett; 2013 Jul; 334(2):338-45. PubMed ID: 22776563 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]